Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

NCT00559286 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped logistic reasons, patients could not be recruited

Conditions

Arterial Hypertension
Diabetes Mellitus Type 2 IRC or NIR

Interventions

DRUG: Telmisartan

Sponsor

RWTH Aachen University

Collaborators

[object Object]
[object Object]
[object Object]